Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.
about
A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapyLow-molecular-weight cyclin E: the missing link between biology and clinical outcomeCharacterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell deathCold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer.Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer.A novel interaction between HER2/neu and cyclin E in breast cancer.MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.Approaches to identifying synthetic lethal interactions in cancer.Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer.Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune responseThe dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing.Nucleotide deficiency promotes genomic instability in early stages of cancer developmentAntiproliferative and Pro-Apoptotic Effect of Novel Nitro-Substituted Hydroxynaphthanilides on Human Cancer Cell Lines.The molecular genetics of breast cancer and targeted therapySynthetic lethality between CCNE1 amplification and loss of BRCA1.Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib.Geranylated flavanone tomentodiplacone B inhibits proliferation of human monocytic leukaemia (THP-1) cells.A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels.Cyclin-dependent kinase 2/cyclin E complex is involved in p120 catenin (p120ctn)-dependent cell growth control: a new role for p120ctn in cancer.MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs.The Proliferative Response to p27 Down-Regulation in Estrogen Plus Progestin Hormonal Therapy is Lost in Breast Tumors.Cyclin E and FGF8 are downstream cell growth regulators in distinct tumor suppressor effects of ANXA7 in hormone-resistant cancer cells of breast versus prostate origin
P2860
Q24538802-94EFDCED-7BA5-4B52-825A-DDEF94451F2EQ24806316-870E0928-8C16-4A38-AA60-51D6CD4777DDQ28482928-C9D6979C-F64E-40CB-B597-FF1DA86F0DB1Q33618433-A1171A4F-C6C0-47D5-B21B-11A9B6319666Q33658276-530EDC70-EBD6-4EA2-A23D-DBDF81DAEDEAQ33747782-CD8ED627-29A2-4637-9455-5BD2062F3713Q33754744-DF4E56A7-F1FB-46BB-9FBF-C220E608F32FQ33976264-0E2BEDF2-6BF5-4E2C-A531-4A3FB6BFEAB4Q34575813-46987F8A-B6F1-44B1-883A-66191BCD4E71Q35647469-1B730D63-8E34-4BBC-B913-D24DB9BE1F79Q35954912-B85BEA1D-500B-4E93-873C-8CC582695EA7Q36096051-976168B8-02BE-42FA-B986-98C91A0721D6Q37018880-6A30706B-B033-465F-9C63-66C74CBA286FQ37087191-A5930EDD-8208-43F3-BCD5-B850E501D8B9Q37209901-EA7A06FD-206B-46AF-B18E-420F738813AEQ37290512-E3ECF17F-32B7-4AC5-BBF7-F6E9FD5874DFQ37353157-8F6D4047-DA67-487A-9DD7-466098310286Q38756596-2069EABB-E70E-4F7B-8257-AFDB6C3BFED4Q39617469-9DD826A3-DE65-4588-A9C5-2FC377FA988EQ39818985-0D1B545C-B49E-49E5-B4B5-DDC2E239338BQ40162937-495C8FDE-A484-4508-A8F7-4F39DE1FD2A7Q42127785-3CCBC2C1-A454-4725-B2B5-E1F737FC19C8Q52727420-E4DB8C90-538A-408C-872F-B44039AC54E3Q58133482-EE2A1FD6-93A0-4A64-B717-0BA33FA24566
P2860
Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cyclin E and its low molecular ...... as targets for cancer therapy.
@ast
Cyclin E and its low molecular ...... as targets for cancer therapy.
@en
type
label
Cyclin E and its low molecular ...... as targets for cancer therapy.
@ast
Cyclin E and its low molecular ...... as targets for cancer therapy.
@en
prefLabel
Cyclin E and its low molecular ...... as targets for cancer therapy.
@ast
Cyclin E and its low molecular ...... as targets for cancer therapy.
@en
P1476
Cyclin E and its low molecular ...... as targets for cancer therapy
@en
P2093
Khandan Keyomarsi
P304
P433
P577
2003-07-01T00:00:00Z